0001193125-12-018518.txt : 20120120 0001193125-12-018518.hdr.sgml : 20120120 20120120150924 ACCESSION NUMBER: 0001193125-12-018518 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120120 DATE AS OF CHANGE: 20120120 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KNIGHT SECURITIES L P CENTRAL INDEX KEY: 0001167589 IRS NUMBER: 223660471 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 525 WASHINGTON BLVD STREET 2: 23RD FLOOR CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 8005447508 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NMT MEDICAL INC CENTRAL INDEX KEY: 0001017259 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 954090463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-48983 FILM NUMBER: 12536888 BUSINESS ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6177370930 MAIL ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: NITINOL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960619 SC 13G 1 d286244dsc13g.htm SCHEDULE 13G Schedule 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Schedule 13G

(Initial Filing)

Under the Securities Exchange Act of 1934

 

 

 

NMT Medical, Inc.

(Name of Issuer)

 

 

 

Common Stock, $.001

(Title of Class of Securities)

 

629294109

(CUSIP Number)

 

December 30, 2011

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

SCHEDULE 13G

 

CUSIP NO. 629294109  

 

  1.   

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)

 

Knight Capital Americas, L.P., formerly Knight Equity Markets, L.P.

22-3660471

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  ¨

 

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

    5.    

SOLE VOTING POWER

 

1,129,129

   6.   

SHARED VOTING POWER

 

Not applicable

   7.   

SOLE DISPOSITIVE POWER

 

1,129,129

   8.   

SHARED DISPOSITIVE POWER

 

Not applicable

  9.

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,129,129

10.

  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11.

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

7.05% based on outstanding shares reported on the issuer’s 10-Q filed with the SEC for period ended September 30, 2010.

12.

  

TYPE OF REPORTING PERSON*

 

BD

ITEM 1(a). Name of Issuer

NMT Medical, Inc.

 

ITEM 1(b). Address of Issuer’s Principal Executive Offices

27 Wormwood Street, Boston, MA 02210-1625

 

ITEM 2(a). Names of Persons Filing

Knight Capital Americas, L.P., formerly Knight Equity Markets, L.P.

 

ITEM 2(b). Address of principal business office

545 Washington Blvd., 3rd Floor

Jersey City, NJ 07310

 

ITEM 2(c). Citizenship

Delaware

 

ITEM 2(d). Title of Class of Securities

Common Stock

 

ITEM 2(e). CUSIP Number

629294109

ITEM 3. If this statement is filed pursuant to Rules 13d-1(b), or 13(d)-2(b), check whether the person filing it is a:

(a) x Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 

ITEM 4. Ownership

 

(a)    Amount beneficially owned   
   1,129,129      
(b)    Percent of class     7.05%      
(c)    Number of shares as to which such person has:   
   (i)    sole power to vote or to direct the vote    1,129,129   
        

 

   
   (ii)    shared power to vote or to direct the vote    Not applicable   
        

 

   
   (iii)    sole power to dispose or to direct the disposition of    1,129,129   
   (iv)    shared power to dispose or to direct the disposition of    Not applicable   
        

 

   

 

ITEM 5. Ownership of Five Percent or Less of a Class

Not applicable

 

ITEM 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable

 

ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

 

ITEM 8. Identification and Classification of Members of the Group

Not applicable.

ITEM 9. Notice of Dissolution of Group

Not applicable.

 

ITEM 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: January 19, 2012

 

Knight Capital Americas, L.P.
By:  

/s/ Michael Corrao

  Michael Corrao
  Director of Compliance